CytomX Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTMX research report →
Companywww.cytomx.com
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer.
- CEO
- Sean A. McCarthy
- IPO
- 2015
- Employees
- 119
- HQ
- South San Francisco, CA, US
Price Chart
Valuation
- Market Cap
- $598.26M
- P/E
- -11.15
- P/S
- 16.83
- P/B
- 2.06
- EV/EBITDA
- -9.26
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.29%
- Op Margin
- -181.92%
- Net Margin
- -166.40%
- ROE
- -36.61%
- ROIC
- -19.70%
Growth & Income
- Revenue
- $76.20M · -44.82%
- Net Income
- $-17,368,000 · -154.50%
- EPS
- $-0.15 · -139.47%
- Op Income
- $-22,364,000
- FCF YoY
- 12.40%
Performance & Tape
- 52W High
- $8.21
- 52W Low
- $1.72
- 50D MA
- $4.41
- 200D MA
- $3.93
- Beta
- 2.17
- Avg Volume
- 6.87M
Get TickerSpark's AI analysis on CTMX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 17, 26 | Chu Yu-Waye | sell | 21,279 |
| Mar 17, 26 | McCarthy Sean A. | sell | 118,969 |
| Mar 17, 26 | BELVIN MARCIA | sell | 31,492 |
| Mar 17, 26 | Ogden Christopher | sell | 19,323 |
| Feb 2, 26 | Lester Rachael | other | 50,000 |
| Feb 2, 26 | Lester Rachael | other | 50,000 |
| Feb 2, 26 | Lester Rachael | other | 20,000 |
| Feb 2, 26 | Chu Yu-Waye | other | 300,000 |
| Feb 2, 26 | Chu Yu-Waye | other | 75,000 |
| Feb 2, 26 | BELVIN MARCIA | other | 60,000 |
Our CTMX Coverage
We haven't published any research on CTMX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CTMX Report →